Author:
Zilli Thomas,Franzese Ciro,Guckenberger Matthias,Giaj-levra Niccolò,Mach Nicolas,Koutsouvelis Nikolaos,Achard Verane,Mcdonald Andrew,Alongi Filippo,Scorsetti Marta,Constantin Guillaume,Bertaut Aurelie,Miralbell Raymond
Reference28 articles.
1. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: alpha/beta = 1.4 (0.9-2.2) Gy;Miralbell;International Journal of Radiation Oncology, Biology, Physics,2012
2. Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer;Catton;Journal of Clinical Oncology,2017
3. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial;Dearnaley;The Lancet Oncology,2016
4. A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapy;Roberts;Radiotherapy and Oncology,2014
5. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction;Brenner;Seminars in Radiation Oncology,2008
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献